...
首页> 外文期刊>Japanese Journal of Pharmacology >Venodilating Action of Nipradilol (K-351) in the Pithed Rat Pretreated with Dihydroergotamine
【24h】

Venodilating Action of Nipradilol (K-351) in the Pithed Rat Pretreated with Dihydroergotamine

机译:Nipradilol(K-351)在二氢麦角胺预处理的小白鼠中的舒张作用

获取原文

摘要

References(18) Cited-By(14) The venodilating action of nipradilol was investigated by monitoring arterial blood pressure (BP), cardiac output (CO), heart rate (HR) and central venous pressure (CVP) in pithed rats treated with dihydroergotamine (DHE). DHE increased CVP and produced a simultaneous rise in BP and CO without appreciable changes in total peripheral resistance (TPR) and HR, indicating that DHE reduces venous capacity through venoconstriction. Nipradilol caused a fall in CVP, BP and CO without changing the TPR in the DHE-pretreated rat. By comparison, hydralazine reduced BP and TPR without changes in CO. Propranolol produced only a transient decrease in BP and TPR. These results indicate that nipradilol dilates venous capacitance vessels and thereby decreases cardiac filling pressure in animals with high venous tone, whereas hydralazine preferentially dilates resistance vessels.
机译:参考文献(18)被引用者(14)通过监测用二氢麦角胺治疗的去髓大鼠的动脉血压(BP),心输出量(CO),心率(HR)和中心静脉压(CVP)来研究尼帕地洛的舒张作用(DHE)。 DHE增加了CVP并同时使BP和CO升高,而总外周阻力(TPR)和HR没有明显变化,表明DHE通过静脉收缩降低了静脉容量。 Nipradilol导致DVP预处理大鼠的CVP,BP和CO下降,而TPR不变。相比之下,肼屈嗪可降低BP和TPR而不会改变CO。普萘洛尔只会使BP和TPR暂时降低。这些结果表明,尼帕地洛扩张了静脉电容血管,从而降低了具有高静脉张力的动物的心脏充盈压,而肼苯哒嗪则优先扩张了阻力血管。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号